State of New Jersey Common Pension Fund D increased its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 1.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 226,572 shares of the company’s stock after acquiring an additional 3,492 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Avantor were worth $3,050,000 at the end of the most recent reporting period.
Several other institutional investors have also made changes to their positions in the business. Rise Advisors LLC bought a new stake in shares of Avantor in the 1st quarter worth about $25,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Avantor by 288.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock worth $28,000 after purchasing an additional 1,263 shares during the last quarter. Wealthquest Corp bought a new stake in shares of Avantor in the 1st quarter worth about $34,000. FNY Investment Advisers LLC bought a new stake in shares of Avantor in the 2nd quarter worth about $36,000. Finally, GAMMA Investing LLC grew its holdings in shares of Avantor by 121.6% in the 1st quarter. GAMMA Investing LLC now owns 3,747 shares of the company’s stock worth $61,000 after purchasing an additional 2,056 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.
Avantor Stock Performance
Avantor stock opened at $15.13 on Tuesday. The company has a current ratio of 0.98, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. Avantor, Inc. has a 1 year low of $10.82 and a 1 year high of $23.70. The company has a market cap of $10.31 billion, a PE ratio of 15.28, a PEG ratio of 5.03 and a beta of 0.98. The company’s 50-day moving average is $13.37 and its two-hundred day moving average is $13.34.
Insider Transactions at Avantor
In other Avantor news, CAO Steven W. Eck sold 3,476 shares of the company’s stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $11.39, for a total transaction of $39,591.64. Following the transaction, the chief accounting officer directly owned 55,068 shares in the company, valued at approximately $627,224.52. This represents a 5.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.20% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on AVTR shares. Evercore ISI lowered their target price on shares of Avantor from $18.00 to $16.00 and set an “outperform” rating on the stock in a report on Monday, August 4th. Wells Fargo & Company lowered their target price on shares of Avantor from $19.00 to $16.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Barclays upped their target price on shares of Avantor from $13.00 to $15.00 and gave the stock an “overweight” rating in a report on Thursday, October 2nd. Jefferies Financial Group reissued a “hold” rating on shares of Avantor in a report on Friday, August 1st. Finally, Stifel Nicolaus set a $12.00 price objective on shares of Avantor and gave the stock a “hold” rating in a report on Monday, August 4th. Seven analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $15.96.
Get Our Latest Analysis on Avantor
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading
- Five stocks we like better than Avantor
- How to Use the MarketBeat Dividend Calculator
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- How to buy stock: A step-by-step guide for beginners
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- Roth IRA Calculator: Calculate Your Potential Returns
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
